| Autor: |
Ozsahin Dilber Uzun, Gelisen Mehmet Ilker, Taiwo Mustapha, Agachan Yasemin, Rahi Dorrin, Uzun Berna |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
The EuroBiotech Journal, Vol 5, Iss s1, Pp 20-25 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2564-615X |
| DOI: |
10.2478/ebtj-2021-0017 |
| Popis: |
The entire globe is struggling with the COVID-19 pandemic since March 11, 2020. There is still a large number of infected patients and death, and there is no proven treatment for the infection yet. This has led to the race in vaccine development to protect people from COVID-19 infection. As of February 3, 2021, there were 289 experimental COVID -19 vaccines in development, 66 of which were in clinical trials with different phases, and 20 of them were in phase 3. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
